PHC2 (NM_004427) Human Tagged ORF Clone Lentiviral Particle
CAT#: RC212697L3V
- LentiORF®
Lenti ORF particles, PHC2 (Myc-DDK tagged) - Human polyhomeotic homolog 2 (Drosophila) (PHC2), transcript variant 2, 200ul, >10^7 TU/mL
Need custom lentivirus service?
Get a free quote
CNY 8,170.00
货期*
详询
规格
Product images
经常一起买 (3)
Specifications
Product Data | |
Product Name | PHC2 (NM_004427) Human Tagged ORF Clone Lentiviral Particle |
Synonyms | EDR2; HPH2; PH2 |
Vector | pLenti-C-Myc-DDK-P2A-Puro |
ACCN | NM_004427 |
ORF Size | 969 bp |
Sequence Data |
The ORF insert of this clone is exactly the same as(RC212697).
|
OTI Disclaimer | The molecular sequence of this clone aligns with the gene accession number as a point of reference only. However, individual transcript sequences of the same gene can differ through naturally occurring variations (e.g. polymorphisms), each with its own valid existence. This clone is substantially in agreement with the reference, but a complete review of all prevailing variants is recommended prior to use. More info |
OTI Annotation | This clone was engineered to express the complete ORF with an expression tag. Expression varies depending on the nature of the gene. |
Reference Data | |
RefSeq | NM_004427.2 |
RefSeq Size | 2597 bp |
RefSeq ORF | 972 bp |
Locus ID | 1912 |
MW | 35.6 kDa |
Gene Summary | In Drosophila melanogaster, the 'Polycomb' group (PcG) of genes are part of a cellular memory system that is responsible for the stable inheritance of gene activity. PcG proteins form a large multimeric, chromatin-associated protein complex. The protein encoded by this gene has homology to the Drosophila PcG protein 'polyhomeotic' (Ph) and is known to heterodimerize with EDR1 and colocalize with BMI1 in interphase nuclei of human cells. The specific function in human cells has not yet been determined. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008] |
Documents
Product Manuals |
FAQs |
SDS |
Resources
You may also need
Customer
Reviews
Loading...